The effect of sugarcane extract syrup in comparison with polyethylene glycol syrup (PEG 40%) in treatment of chronic constipation in children aged 4 to 12 years

The effect of sugarcane extract syrup in comparison with PEG syrup (40%) in treatment of chronic constipation in children aged 4 to 12 years

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT201710219204N2

Enrollment

Registered

2017-11-09

Start date

2017-05-22

Completion date

Unknown

Last updated

2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Functional Constipation. Functional Constipation

Interventions

Intervention 1: Group A, for 1 month will receive sugarcane extract syrup, 1-1.5 milliliter per kilogram of body weight, daily. Intervention 2: Group B, for 1 month will receive polyethylene glycol sy

Treatment - Drugs

Group A, for 1 month will receive sugarcane extract syrup, 1-1.5 milliliter per kilogram of body weight, daily.

Group B, for 1 month will receive polyethylene glycol syrup (PEG 40%), 1-1.5 milliliter per kilogram of body weight, daily.

Eligibility

Sex/Gender

All

Age

4 Years to 12 Years

Inclusion criteria

Inclusion criteria: Inclusion criteria: Children aged 4 to 12 years; Chronic functional constipation; having at least 2 of the 6 Rome III criteria Exclusion criteria: Taking any type of laxative 4 weeks before the trial; diabetes, autoimmune diseases, hypothyroidism, cystic fibrosis, history of intestinal surgery

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

Measure	Time frame
Frequency of bowel habit per week. Timepoint: Before intervention, two and four weeks after intervention. Method of measurement: Rome III standard questionnaire.	—

Secondary

Measure	Time frame
Frequency of painful bowel habit per week. Timepoint: Before intervention, two and four weeks after intervention. Method of measurement: Rome III standard questionnaire.;Possible serological side effects. Timepoint: Before intervention, four weeks after intervention. Method of measurement: Serlogical tests.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr. Azadeh Hamedi; Dr. Seyed Mohsen Dehghani

Shiraz Univesity of Medical Sciences

hamediaz@sums.ac.ir+98 71 3612 1000

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026